Physician profile
Michael A Persky
NPI 1659404333
$13,842.77
in general payments reported to CMS, 2019-2025
7 companies · $1,730 in 2025
The $1,730 reported for 2025 was more than what 92% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $883 · 2020: $337 · 2021: $1,356 · 2022: $4,328 · 2023: $2,740 · 2024: $2,470 · 2025: $1,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,894 · Food and Beverage: $2,028 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,894.40 |
| Food and Beverage | $2,028.48 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,041.78 | 2023-2025 | |
| Galderma Laboratories, L.P. | $3,740.26 | 2019-2025 | |
| Allergan, INC. | $3,522.94 | 2019-2023 | |
| Revance Therapeutics, INC. | $195.69 | 2024-2025 | Daxxify |
| Merz North America, INC. | $165.67 | 2019-2020 | |
| Integra Lifesciences Corporation | $135.47 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solta Medical, A Division of Bausch Health US, LLC | $40.96 | 2023-2024 | Clear+Brilliant, Fraxel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Persky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.